<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20230313057710N3</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-08-14</date_registration>
      <primary_sponsor>Esfahan University of Medical Sciences</primary_sponsor>
      <public_title>Effect of prewarming and precooling of mucosal injection site on maxillary central incisor labial infiltration anesthesia pain</public_title>
      <acronym></acronym>
      <scientific_title>Effect of prewarming and precooling of mucosal injection site on maxillary central incisor labial infiltration anesthesia pain</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2017-12-23</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>20</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/71624</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Crossover, Purpose: Treatment, Other design features: A clinical trial study was designed in which each participant received 3 injections in 3 consecutive days on the same central maxillary tooth. The statistician used the random assignment by lottery for determining sequence of intervention allocation to the participants. Therefore, the participants were assigned on the first day as the control group (receiving labial infiltration injection of unilateral maxillary central tooth), on the second day as experimental group 1 (applying an ice pack), and on the third day as experimental group 2 (warm pack). Comparison of pain between groups (after intervention) and before-after was done, Randomization description: In the present study, the participants in the control, intervention 1 and intervention 2 groups were the same, and selected using available sampling method. The statistician used the random assignment by lottery for determining sequence of intervention allocation to the participants. Therefore, the participants were assigned on the first day as the control group, on the second day as experimental group 1 (applying an ice pack), and on the third day as experimental group 2 (warm pack), Blinding description: Blinding of participants was not possible due to the nature of the study. However, the statistician who analyzed the results was blinded to the group allocation of data.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Maxillary central incisor labial infiltration anesthesia pain.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group1: َAfter placing an ice pack over the injection site in the labial mucosa for 1 minute, Labial infiltration anesthesia of maxillary central incisors with local anesthesia (lidocaine) was done. The ice pack was fabricated by filling the fingers of a Latex glove with water, tying it, cutting the rest of the glove, and placing it in a freezer. All ice packs were checked to ensure 0°C temperature without thawing. All injections were performed by an aspirating dental injection syringe (Novocol Ontario, Canada) with a short 27-gauge needle (Made in France). 0.6 mL of 2% lidocaine with 1:80,000 Epinephrine was injected into the labial vestibule of maxillary central incisor. The needle was inserted into the tissue by 3-5 mm, aspiration was performed, and the anesthetic agent was released. Upon completion of injection, the participants expressed the level of pain they experienced during needle insertion and release of anesthetic agent using a 100-mm  visual analog scale (VAS) , and Wong-Baker Faces pain rating scale (WBFPRS). Intervention 2: Intervention group2: After placing an heat pack over the injection site in the labial mucosa for 1 minute, Labial infiltration anesthesia of maxillary central incisors with local anesthesia (lidocaine) was done. The heat pack was fabricated by filling a Latex glove with water, tying it, and heating it in a water bath at 50°C (Figure 1). The water temperature was measured after removal from the water bath and prior to placement over the mucosa. To obtain optimal results, a minimum temperature rise of 3-4°C of the mucosa was required. All injections were performed by an aspirating dental injection syringe (Novocol Ontario, Canada) with a short 27-gauge needle (Made in France). 0.6 mL of 2% lidocaine with 1:80,000 Epinephrine was injected into the labial vestibule of maxillary central incisor. The needle was inserted into the tissue by 3-5 mm, aspiration was performed, and the anesthetic agent was released. Upon completion of injection, the participants expressed the level of pain they experienced during needle insertion and release of anesthetic agent using a 100-mm  visual analog scale (VAS) , and Wong-Baker Faces pain rating scale (WBFPRS). Intervention 3: Control group: Labial infiltration anesthesia of maxillary central incisors was performed with lidocaine without the intervention of cold or heat packs. All injections were performed by an aspirating dental injection syringe (Novocol Ontario, Canada) with a short 27-gauge needle (Made in France). 0.6 mL of 2% lidocaine with 1:80,000 Epinephrine was injected into the labial vestibule of maxillary central incisor. The needle was inserted into the tissue by 3-5 mm, aspiration was performed, and the anesthetic agent was released. Upon completion of injection, the participants expressed the level of pain they experienced during needle insertion and release of anesthetic agent using a 100-mm  visual analog scale (VAS) , and Wong-Baker Faces pain rating scale (WBFPRS).</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is If the article is submitted and the data file is needed, it will be made available</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Zahra Khosravani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Isfahan University of Medical Sciences, Hezar Jerib street, Isfahan, Iran</address>
        <city>Isfahan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8174673461</zip>
        <telephone>+98 31 3668 0048</telephone>
        <email>khosravanii.zahra73sums@gmail.com</email>
        <affiliation>Esfahan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Armita Vali Sichani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Isfahan University of Medical Sciences, Hezar Jerib street, Isfahan</address>
        <city>Isfahan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8174673461</zip>
        <telephone>+98 31 3668 0048</telephone>
        <email>a.valisichani@dnt.mui.ac.ir</email>
        <affiliation>Esfahan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Presence of sound maxillary central and lateral incisors</inclusion_criteria>
      <agemin>no limit</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>History of anaphylactic shock
Pregnancy
History of trauma to maxillary central incisors
History of allergy to lidocaine and sulfide
Present of severe periodontal disease
Intake of medications affecting pain perception (such as beta blockers and opioids)
Intake of medications interacting with local anesthetic agent
Present of fever, and systemic diseases</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>K00-K14</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>XI Diseases of the digestive system</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Devices</i_code>
      <i_code>Treatment - Devices</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group1: َAfter placing an ice pack over the injection site in the labial mucosa for 1 minute, Labial infiltration anesthesia of maxillary central incisors with local anesthesia (lidocaine) was done. The ice pack was fabricated by filling the fingers of a Latex glove with water, tying it, cutting the rest of the glove, and placing it in a freezer. All ice packs were checked to ensure 0°C temperature without thawing. All injections were performed by an aspirating dental injection syringe (Novocol Ontario, Canada) with a short 27-gauge needle (Made in France). 0.6 mL of 2% lidocaine with 1:80,000 Epinephrine was injected into the labial vestibule of maxillary central incisor. The needle was inserted into the tissue by 3-5 mm, aspiration was performed, and the anesthetic agent was released. Upon completion of injection, the participants expressed the level of pain they experienced during needle insertion and release of anesthetic agent using a 100-mm  visual analog scale (VAS) , and Wong-Baker Faces pain rating scale (WBFPRS).</i_keyword>
      <i_keyword>Intervention group2: After placing an heat pack over the injection site in the labial mucosa for 1 minute, Labial infiltration anesthesia of maxillary central incisors with local anesthesia (lidocaine) was done. The heat pack was fabricated by filling a Latex glove with water, tying it, and heating it in a water bath at 50°C (Figure 1). The water temperature was measured after removal from the water bath and prior to placement over the mucosa. To obtain optimal results, a minimum temperature rise of 3-4°C of the mucosa was required. All injections were performed by an aspirating dental injection syringe (Novocol Ontario, Canada) with a short 27-gauge needle (Made in France). 0.6 mL of 2% lidocaine with 1:80,000 Epinephrine was injected into the labial vestibule of maxillary central incisor. The needle was inserted into the tissue by 3-5 mm, aspiration was performed, and the anesthetic agent was released. Upon completion of injection, the participants expressed the level of pain they experienced during needle insertion and release of anesthetic agent using a 100-mm  visual analog scale (VAS) , and Wong-Baker Faces pain rating scale (WBFPRS).</i_keyword>
      <i_keyword>Control group: Labial infiltration anesthesia of maxillary central incisors was performed with lidocaine without the intervention of cold or heat packs. All injections were performed by an aspirating dental injection syringe (Novocol Ontario, Canada) with a short 27-gauge needle (Made in France). 0.6 mL of 2% lidocaine with 1:80,000 Epinephrine was injected into the labial vestibule of maxillary central incisor. The needle was inserted into the tissue by 3-5 mm, aspiration was performed, and the anesthetic agent was released. Upon completion of injection, the participants expressed the level of pain they experienced during needle insertion and release of anesthetic agent using a 100-mm  visual analog scale (VAS) , and Wong-Baker Faces pain rating scale (WBFPRS).</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Maxillary central incisor labial infiltration anesthesia pain. Timepoint: During needle insertion and release of anesthetic agent. Method of measurement: The participants expressed the level of pain they experienced during needle insertion and release of anesthetic agent using a 100-mm visual analog scale (VAS), and Wong-Baker Faces pain rating scale.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Esfahan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2019-06-26</approval_date>
        <contact_name>Research Ethix Committee of Isfahan University of Medical Sciences</contact_name>
        <contact_address>Hezar Jerib street, Isfahan University of Medical Sciences, , Isfahan, Iran Isfahan Isfehan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
